Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.
Quick Stats
Jun 24, 202663.9
AI Score
BUY0.94
Volume Ratio
Aug 06, 2026
Next Earnings
17
+ve Days (30d)
12
-ve Days (30d)
CRMD Stock Summary
Last updated Jun 24, 2026
CRMD is currently trading at $8.39, positioned below its 200-day moving average of $9.1, suggesting bearish momentum. The stock has a 52-week range of $6.125 to $16.89.
Technical Analysis: The 50-day moving average stands at $8.03, which is below the current price, signaling bullish near-term momentum. The RSI (Relative Strength Index) reads 56.278, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.165, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates CRMD at 63.9/100 with a BUY recommendation.
CRMD (CorMedix Inc.) Indicators
Last updated Jun 24, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 56.278 |
| CMF (20) | -0.165 |
| ROC (10) | -0.347 |
| ADX (14) | 42.109 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | 0.206 |
| AROONOSC (14) | 42.857 |
| WILLAMS %R (14) | -49.786 |
| MFI (14) | 68.288 |
CRMD Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
CRMD Price vs Max Options Open Interest
CRMD Max Change In Options Open Interest
CRMD Options - Sort by Max open Interest (near term)
24th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CRMD Daily Out of Money Options - Sort by Max open Interest (near term)
24th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CRMD Daily In the Money Options - Sort by Max open Interest (near term)
24th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CRMD Most Active Options by Volume(near term)
24th June 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
CorMedix Inc. is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
CRMD Moving Averages Analysis
CorMedix Inc. has been above 50 day sma 1 times in last 30 days. Last time it was above 50 day sma was on Jun 24, 2026
CRMD (CorMedix Inc.) Simple Moving Averages
Moving Averages are last updated Jun 24, 2026
| Days | MA |
|---|---|
| 10 | 8.69 |
| 20 | 8.56 |
| 30 | 8.32 |
| 50 | 8.03 |
| 100 | 7.52 |
| 200 | 9.1 |
CRMD Fundamental Analysis
| P/E (Forward) | 16.8919 |
| P/E (Trailing) | 3.9631 |
| Market Cap ($) | 674.7 million |
| Earnings/Share ($) | 2.17 |
| Net Proft Margin (%) | 0.4525 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | 0.5 |
| EPS Estimate Next Year ($) | 0.086 |
| WallStreet Target Price ($) | 15.2 |
| Most Recent Quarter |
CorMedix Inc. becomes the world's most valuable pharmaceutical company with a market capitalization above $3 trillion. The company's shares surged 9.4% after reporting strong second-quarter revenue and raising its full-year outlook. The milestone was achieved under Chief Executive Joe Todisco through focused acquisitions, manufacturing expansion, and late-stage trial wins. Some investors are hopeful for meme stock status to pump the stock and kill the shorts.
Updated 2026-02-22 05:00:01